ES2869904T3 - Compuestos de Antrodia camphorata, método para prepararlos y uso de los mismos - Google Patents

Compuestos de Antrodia camphorata, método para prepararlos y uso de los mismos Download PDF

Info

Publication number
ES2869904T3
ES2869904T3 ES15875258T ES15875258T ES2869904T3 ES 2869904 T3 ES2869904 T3 ES 2869904T3 ES 15875258 T ES15875258 T ES 15875258T ES 15875258 T ES15875258 T ES 15875258T ES 2869904 T3 ES2869904 T3 ES 2869904T3
Authority
ES
Spain
Prior art keywords
cancer
pharmaceutical composition
compounds
antrodia camphorata
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES15875258T
Other languages
English (en)
Spanish (es)
Inventor
Chiung-Lin Liu
Wei-Tse Tsai
Kai-Hsin Hsieh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oneness Biotech Co Ltd
Original Assignee
Oneness Biotech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oneness Biotech Co Ltd filed Critical Oneness Biotech Co Ltd
Application granted granted Critical
Publication of ES2869904T3 publication Critical patent/ES2869904T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
    • C07C69/12—Acetic acid esters
    • C07C69/21—Acetic acid esters of hydroxy compounds with more than three hydroxy groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/64—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of functional groups containing oxygen only in singly bound form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/78—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/78—Separation; Purification; Stabilisation; Use of additives
    • C07C45/79—Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/527—Unsaturated compounds containing keto groups bound to rings other than six-membered aromatic rings
    • C07C49/577—Unsaturated compounds containing keto groups bound to rings other than six-membered aromatic rings containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/48—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/48—Separation; Purification; Stabilisation; Use of additives
    • C07C67/56—Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
ES15875258T 2014-12-30 2015-12-30 Compuestos de Antrodia camphorata, método para prepararlos y uso de los mismos Active ES2869904T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462098177P 2014-12-30 2014-12-30
PCT/CN2015/099894 WO2016107582A1 (en) 2014-12-30 2015-12-30 Compounds from antrodia camphorata, method for preparing the same and use thereof

Publications (1)

Publication Number Publication Date
ES2869904T3 true ES2869904T3 (es) 2021-10-26

Family

ID=56163420

Family Applications (1)

Application Number Title Priority Date Filing Date
ES15875258T Active ES2869904T3 (es) 2014-12-30 2015-12-30 Compuestos de Antrodia camphorata, método para prepararlos y uso de los mismos

Country Status (9)

Country Link
US (1) US9884801B2 (enExample)
EP (1) EP3240772B1 (enExample)
JP (1) JP6896630B2 (enExample)
CN (1) CN105732381B (enExample)
ES (1) ES2869904T3 (enExample)
MY (1) MY173104A (enExample)
PL (1) PL3240772T3 (enExample)
TW (1) TWI648257B (enExample)
WO (1) WO2016107582A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106063800B (zh) * 2016-08-01 2020-02-18 上海交通大学 牛樟芝在抗前列腺增生药物中的应用
EP3541777B1 (en) * 2016-11-18 2023-01-11 Golden Biotechnology Corporation Compositions for treating atopic dermatitis
CN108409571A (zh) * 2018-03-23 2018-08-17 中国药科大学 从金刚纂中提取的用于治疗癌症的化合物
CN113795258B (zh) * 2019-02-25 2024-04-16 吉亚生技控股股份有限公司 抑制病毒感染的方法及组合物
CN112851510B (zh) * 2021-01-27 2022-07-19 Ａｇｃ株式会社 他氟前列素的纯化方法
CN113831221B (zh) * 2021-09-18 2023-04-07 云南民族大学 一种倍半萜类化合物及其制备方法与应用
CN114487252B (zh) * 2021-12-28 2024-03-26 陕西嘉禾生物科技股份有限公司 一种用于区别牛樟芝和牛樟木的薄层色谱鉴别方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6247838B1 (en) 1998-11-24 2001-06-19 The Boc Group, Inc. Method for producing a liquid mixture having a predetermined concentration of a specified component
US7531627B2 (en) 2003-12-19 2009-05-12 Po-Jung Chien Protein ACA1 of Antrodia camphorata
US7109232B2 (en) 2004-03-08 2006-09-19 Simpson Biotech Co., Ltd. Compounds from Antrodia camphorata having anti-inflammatory and anti-tumor activity
ATE513823T1 (de) 2004-08-17 2011-07-15 Simpson Biotech Co Ltd Mischung und verbindungen von mycelien von antrodia camphorata und deren verwendung
US7601854B2 (en) 2006-10-25 2009-10-13 Kang Jian Biotech Corp., Ltd. Diterpenes from the fruiting body of Antrodia camphorata and pharmaceutical compositions thereof
TW200829234A (en) * 2007-01-08 2008-07-16 Golden Biotechnology Corp Antrodia camphorata isophorone extract
TW200918498A (en) 2007-10-19 2009-05-01 Golden Biotechnology Corp Novel compound isolated from Antrodia camphorate extracts
CN101417934B (zh) * 2007-10-24 2012-04-18 国鼎生物科技股份有限公司 分离自牛樟芝萃取物的化合物
TW201000112A (en) 2008-06-18 2010-01-01 Mackay Memorial Hospital Use of dehydrosulphurenic acid for inhibiting the growth of cancer cells
US8309611B2 (en) * 2010-09-20 2012-11-13 Golden Biotechnology Corporation Methods and compositions for treating lung cancer
CN103796647A (zh) * 2011-06-10 2014-05-14 国鼎生物科技股份有限公司 用于治疗脑癌的方法和组合物
CN103570531A (zh) * 2012-07-25 2014-02-12 丽丰实业股份有限公司 樟芝菌丝体的化合物及其用途
JP5908002B2 (ja) * 2013-03-20 2016-04-26 卉菱 曽 ベニクスノキタケに含まれる化合物及びその用途
TWI583376B (zh) * 2013-03-20 2017-05-21 曾卉菱 Compounds isolated from Antelroxicus and their use
CN104177240B (zh) * 2013-05-28 2016-10-19 曾卉菱 分离自牛樟芝的化合物、萃取物及其用途
CN104211627A (zh) * 2013-05-29 2014-12-17 曾卉菱 牛樟芝化合物、萃取物及其用途
US9249117B2 (en) * 2014-05-20 2016-02-02 Hui Ling Tseng Use of compounds from Antrodia camphorata in manufacturing medicaments for treating kidney diseases

Also Published As

Publication number Publication date
TWI648257B (zh) 2019-01-21
EP3240772A1 (en) 2017-11-08
JP2018507175A (ja) 2018-03-15
CN105732381B (zh) 2021-07-20
JP6896630B2 (ja) 2021-06-30
PL3240772T3 (pl) 2021-06-28
TW201623208A (zh) 2016-07-01
MY173104A (en) 2019-12-26
WO2016107582A1 (en) 2016-07-07
EP3240772B1 (en) 2021-03-03
US9884801B2 (en) 2018-02-06
EP3240772A4 (en) 2018-08-29
US20160185703A1 (en) 2016-06-30
CN105732381A (zh) 2016-07-06

Similar Documents

Publication Publication Date Title
EP3240772B1 (en) Compounds from antrodia camphorata, method for preparing the same and use thereof
US8075923B2 (en) Use of hederagenin 3-O-α-L-rhamnopyranosyl(1→2)-(β-D-glucopyranosyl(1→4)-α-L-arabinopyranoside or an extract from pulsatillae radix containing the same as a therapeutic agent for solid tumors
CN103936590B (zh) 大戟属中的二萜类化合物及其药物组合物和其在制药中的应用
CN104024212B (zh) 巨大戟烷型二萜化合物及含有它的用于治疗或预防病毒感染疾病的药物组合物
CN105566271B (zh) 双黄酮化合物及其制备治疗癌症的药物的用途
CN104892713A (zh) 葫芦素c及其类似物的制备方法与应用
CN106176716B (zh) 瑞香烷型二萜化合物pimelotide C的新用途
CN115894418A (zh) 蒙古蒿内酯a-f及其药物组合物和其制备方法与应用
CN111253462B (zh) 一种白桦脂醇衍生物及其制备方法和应用
CN100526330C (zh) 簇生沿丝伞石油醚提取物及制备方法以及在制备治疗肿瘤的药物用途
CN101239964B (zh) 15-氧代绣线菊内酯，其药物组合物和其制备方法及其应用
CN100569240C (zh) 橙皮苷和/或柚皮苷的制药用途
US10766922B2 (en) Substituted steroids for the treatment of cancer
CN1836665B (zh) 新橙皮苷或其组合物的制药用途
CN101590035B (zh) 异戊烯基取代的脱氢水飞蓟宾双醚化合物在制备抗癌药物中的应用
CN101336917A (zh) 番荔枝内酯化合物在制备治疗肺癌或乳腺癌药物中的应用
CN107674054A (zh) 一类新骨架杂萜化合物，其制备方法、药物组合物和抗肿瘤应用
CN105601692B (zh) 黄绿蜜环菌中麦角甾醇单体化合物的提取方法及其应用
CN1900046B (zh) 贝壳杉烷型二萜化合物及其制备方法与应用
CN111529515A (zh) 12,15-二氧-α-蛇床烯在制药中的应用
CN101336918B (zh) 番荔枝内酯化合物在制备治疗肺癌或乳腺癌药物中的应用
CN101062045B (zh) 一类三萜皂苷化合物在制备肿瘤药物中的用途
CN115611796A (zh) 薄荷醇单萜二聚体冷水花醇乙及其在制备抗肿瘤药物中的用途
CN102008463A (zh) 番荔枝内酯化合物在制备治疗乳腺癌药物中的应用
CN105601602B (zh) 黄绿蜜环菌中大豆素单体化合物的提取方法及其应用